Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAdagio Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/15/2022 | Q2 2022 | -$0.57 | -$0.47 | 0.1 | N/A | $0 |
| 05/13/2022 | Q1 2022 | -$0.82 | -$0.93 | -0.11 | N/A | $0 |
| 03/31/2022 | Q4 2021 | N/A | -$2.28 | N/A | N/A | $0 |
| 11/15/2021 | Q3 2021 | -$0.74 | -$0.00 | 0.74 | N/A | $3 |
| 09/20/2021 | Q2 2021 | -$0.80 | $0.00 | N/A | N/A | $0 |
| 03/30/2021 | Q1 2021 | N/A | -$0.61 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Adagio Therapeutics, Inc. Earnings: FAQ's
Adagio Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, September 19th, 2022 based offlast year's report dates.
In the previous quarter, Adagio Therapeutics, Inc. (:ADGI) reported $-0.47 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.57 by $0.1.
The conference call for Adagio Therapeutics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Adagio Therapeutics, Inc.'s latest earnings report can be read online.
Adagio Therapeutics, Inc. (:ADGI) has a recorded net income of $-226,790,000.Adagio Therapeutics, Inc. has generated $-2.04 earnings per share over the last four quarters.
Adagio Therapeutics, Inc. (:ADGI) has a price-to-earnings ratio of -0.71 and price/earnings-to-growth ratio is -0.04.